Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue
This stock is making big moves on the heels of positive interim data from phase 1 human trials of Moderna's COVID-19 vaccine candidate.
Full Article
Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue
Motley Fool
0 shares
1 views
You might like
Related news coverage
Moderna falls 20% amid reports that insiders have sold $89 million in shares this year as the stock has spiked (MRNA)
Business Insider
· *Moderna dropped as much as 20% on Wednesday amid a report from Stat News that insiders at the biotech company have liquidated..
Dow leaps 530 points as hopes for a smooth reopening gain traction
Business Insider
Advertisement
More coverage
The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)
Business Insider
· The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine.
· The..
It's a perfect storm of stupid in the stock market right now
Business Insider